Summary
- Current Price
- As of today, RAPP price is $27.54, up +8.72% on
- Current Price All-Time High
- RAPP price is currently -47.97% below its historical high of $52.93 set on
- Market Cap
- RAPP current market cap is $1B, up +4.72% over the past 365 days
- Revenue
- RAPP current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for RAPP is on
Profile
| Metric | Value |
|---|---|
| Full Name | Rapport Therapeutics, Inc. |
| Ticker | NASDAQ: RAPP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | rapportrx.com |
| Employees | 69 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $27.54 | |
| Price, 1D Change | +8.72% | |
| $1B | ||
| - | ||
| - | ||
| 1.22 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.86 | ||
| EPS, 1Y Change | -33.76% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.86 | ||
| EPS Estimate | -$4.04 | N/A |
| EPS Est. Change | -41.06% | N/A |
| $0.00 | ||
| Revenue Estimate | $20.06M | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $27.54 | |
| Price Target | $62.00 | - |
| Price Tgt. Change | +125.13% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$13.97 | -$2.14 | +84.68% | |
| -$2.85 | -$2.86 | -0.57% | |
| -$4.04 | N/A | -41.06% | |
| -$5.11 | N/A | -78.39% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $20.06M | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $27.54 | |
| $35.70 | ||
| $38.19 | ||
| $35.15 | ||
| $34.78 | ||
| -$3.16 | ||
| 1.22 | ||
| $2.52 | ||
| 38.38 | ||
| 109.30% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.86 | ||
| -$1.02M | ||
| - | ||
| -$125.10M | ||
| - | ||
| -$111.48M | ||
| - | ||
| -$124.08M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.02 | ||
| 26.17 | ||
| 26.17 | ||
| - | ||
| - | ||
| 28.21 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 66.07 | ||
| 3.12 | ||
| -5.87 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $484.65M | ||
| $490.64M | ||
| $512.43M | ||
| $498.56M | ||
| $27.78M | ||
| $19.05M | ||
| $11.48M | ||
| $2.76M | ||
| $4.19M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $111.48M | ||
| $124.08M | ||
| $1.02M | ||
| $0.00 | ||
| $1.02M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$87.47M | ||
| -$187.47M | ||
| $270.79M | ||
| $616.00K | ||
| -$88.09M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wolfe Research | ||
| UBS | ||
| Guggenheim | ||
| BTIG | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| BTIG | → | |
| Leerink Partners | ||
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with RAPP
FAQ
- What is the ticker symbol for Rapport Therapeutics, Inc.?
- The ticker symbol for Rapport Therapeutics, Inc. is NASDAQ:RAPP
- Does Rapport Therapeutics, Inc. pay dividends?
- No, Rapport Therapeutics, Inc. does not pay dividends
- What sector is Rapport Therapeutics, Inc. in?
- Rapport Therapeutics, Inc. is in the Healthcare sector
- What industry is Rapport Therapeutics, Inc. in?
- Rapport Therapeutics, Inc. is in the Biotechnology industry
- What country is Rapport Therapeutics, Inc. based in?
- Rapport Therapeutics, Inc. is headquartered in United States
- When did Rapport Therapeutics, Inc. go public?
- Rapport Therapeutics, Inc. initial public offering (IPO) was on June 7, 2024
- Is Rapport Therapeutics, Inc. in the S&P 500?
- No, Rapport Therapeutics, Inc. is not included in the S&P 500 index
- Is Rapport Therapeutics, Inc. in the NASDAQ 100?
- No, Rapport Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Rapport Therapeutics, Inc. in the Dow Jones?
- No, Rapport Therapeutics, Inc. is not included in the Dow Jones index
- When was Rapport Therapeutics, Inc. last earnings report?
- Rapport Therapeutics, Inc.'s most recent earnings report was on August 5, 2026
- When does Rapport Therapeutics, Inc. report earnings?
- The next expected earnings date for Rapport Therapeutics, Inc. is November 5, 2026
Data Sources & References
- RAPP Official Website www.rapportrx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/2012593/000119312526099360/0001193125-26-099360-index.htm
- RAPP Profile on Yahoo Finance finance.yahoo.com/quote/RAPP
- RAPP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rapp